Robert J. Gould

Insider Reports History

Location
C/O Epizyme, Inc., 400 Technology Square, 4 Th Floor, Cambridge, MA
Signature
/s/ Greg Tourangeau, as attorney-in-fact for Robert J. Gould
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert J. Gould:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 36K Jun 26, 2025 Direct
Turnstone Biologics Corp. Director Stock Option (Right to Buy) 12.8K Jun 3, 2024 Direct

Insider Reports Filed by Robert J. Gould

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FULC Fulcrum Therapeutics, Inc. Jun 26, 2025 1 $0 4 Jun 30, 2025 Director
FULC Fulcrum Therapeutics, Inc. Jun 17, 2024 1 $0 4 Jun 18, 2024 Director
TSBX Turnstone Biologics Corp. Jun 3, 2024 1 $0 4 Jul 2, 2024 Director
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Director
FULC Fulcrum Therapeutics, Inc. Jun 27, 2023 1 $0 4 Jun 29, 2023 Interim President & CEO, Director
FULC Fulcrum Therapeutics, Inc. Jan 13, 2023 1 -$101K 4 Jan 13, 2023 Interim President & CEO, Director
FULC Fulcrum Therapeutics, Inc. Jun 27, 2022 1 $0 4 Jun 29, 2022 Director
FULC Fulcrum Therapeutics, Inc. Jun 7, 2022 3 -$17.8K 4 Jun 8, 2022 Director
FULC Fulcrum Therapeutics, Inc. Jun 2, 2022 9 -$10.5K 4 Jun 6, 2022 Director
FULC Fulcrum Therapeutics, Inc. Apr 7, 2022 3 -$91.1K 4 Apr 11, 2022 Director
FULC Fulcrum Therapeutics, Inc. Apr 1, 2022 9 -$1.54M 4 Apr 5, 2022 Director